These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 20104563

  • 1. Toward a consensus model of the HERG potassium channel.
    Stary A, Wacker SJ, Boukharta L, Zachariae U, Karimi-Nejad Y, Aqvist J, Vriend G, de Groot BL.
    ChemMedChem; 2010 Mar 01; 5(3):455-67. PubMed ID: 20104563
    [Abstract] [Full Text] [Related]

  • 2. A novel structure-based virtual screening model for the hERG channel blockers.
    Du L, Li M, You Q, Xia L.
    Biochem Biophys Res Commun; 2007 Apr 20; 355(4):889-94. PubMed ID: 17331468
    [Abstract] [Full Text] [Related]

  • 3. Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition.
    Yi H, Cao Z, Yin S, Dai C, Wu Y, Li W.
    J Proteome Res; 2007 Feb 20; 6(2):611-20. PubMed ID: 17269718
    [Abstract] [Full Text] [Related]

  • 4. Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel.
    Karczewski J, Wang J, Kane SA, Kiss L, Koblan KS, Culberson JC, Spencer RH.
    Biochem Pharmacol; 2009 May 15; 77(10):1602-11. PubMed ID: 19426697
    [Abstract] [Full Text] [Related]

  • 5. Modeling the hERG potassium channel in a phospholipid bilayer: Molecular dynamics and drug docking studies.
    Masetti M, Cavalli A, Recanatini M.
    J Comput Chem; 2008 Apr 15; 29(5):795-808. PubMed ID: 17926340
    [Abstract] [Full Text] [Related]

  • 6. Molecular dynamics and continuum electrostatics studies of inactivation in the HERG potassium channel.
    Kutteh R, Vandenberg JI, Kuyucak S.
    J Phys Chem B; 2007 Feb 08; 111(5):1090-8. PubMed ID: 17266262
    [Abstract] [Full Text] [Related]

  • 7. Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach.
    Imai YN, Ryu S, Oiki S.
    J Med Chem; 2009 Mar 26; 52(6):1630-8. PubMed ID: 19260734
    [Abstract] [Full Text] [Related]

  • 8. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E, Lozinskaya IM, Lin Z, Semus SF, Blaney FE, Willette RN, Xu X.
    Mol Pharmacol; 2008 Mar 26; 73(3):639-51. PubMed ID: 18042732
    [Abstract] [Full Text] [Related]

  • 9. Block of the hERG channel by bupivacaine: Electrophysiological and modeling insights towards stereochemical optimization.
    Sintra Grilo L, Carrupt PA, Abriel H, Daina A.
    Eur J Med Chem; 2011 Aug 26; 46(8):3486-98. PubMed ID: 21624711
    [Abstract] [Full Text] [Related]

  • 10. Molecular determinants of hERG channel block by terfenadine and cisapride.
    Kamiya K, Niwa R, Morishima M, Honjo H, Sanguinetti MC.
    J Pharmacol Sci; 2008 Nov 26; 108(3):301-7. PubMed ID: 18987434
    [Abstract] [Full Text] [Related]

  • 11. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques.
    Ekins S, Balakin KV, Savchuk N, Ivanenkov Y.
    J Med Chem; 2006 Aug 24; 49(17):5059-71. PubMed ID: 16913696
    [Abstract] [Full Text] [Related]

  • 12. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY, Yang SJ.
    Yao Xue Xue Bao; 2007 Jul 24; 42(7):687-91. PubMed ID: 17882949
    [Abstract] [Full Text] [Related]

  • 13. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
    Zachariae U, Giordanetto F, Leach AG.
    J Med Chem; 2009 Jul 23; 52(14):4266-76. PubMed ID: 19534531
    [Abstract] [Full Text] [Related]

  • 14. Physicochemical features of the HERG channel drug binding site.
    Fernandez D, Ghanta A, Kauffman GW, Sanguinetti MC.
    J Biol Chem; 2004 Mar 12; 279(11):10120-7. PubMed ID: 14699101
    [Abstract] [Full Text] [Related]

  • 15. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies.
    Farid R, Day T, Friesner RA, Pearlstein RA.
    Bioorg Med Chem; 2006 May 01; 14(9):3160-73. PubMed ID: 16413785
    [Abstract] [Full Text] [Related]

  • 16. Topological mapping of the asymmetric drug binding to the human ether-à-go-go-related gene product (HERG) potassium channel by use of tandem dimers.
    Myokai T, Ryu S, Shimizu H, Oiki S.
    Mol Pharmacol; 2008 Jun 01; 73(6):1643-51. PubMed ID: 18326583
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis of the first sulfur-35-labeled hERG radioligand.
    Raab CE, Butcher JW, Connolly TM, Karczewski J, Yu NX, Staskiewicz SJ, Liverton N, Dean DC, Melillo DG.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1692-5. PubMed ID: 16377185
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.